{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:30:58Z","timestamp":1793946658536,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eclinm.2026.103890","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:54:46Z","timestamp":1781564086000},"page":"103890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Challenges and possible solutions towards reaching global cervical cancer elimination"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-5206","authenticated-orcid":false,"given":"Laila Sara","family":"Arroyo M\u00fchr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2026.103890_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eclinm.2026.103890_bib2","series-title":"Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem","year":"2020"},{"issue":"26","key":"10.1016\/j.eclinm.2026.103890_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126400","article-title":"IPVS STATEMENT on HPV vaccination: no longer supply constraints: towards achieving WHO vaccine targets","volume":"42","author":"Garland","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.103890_bib4","series-title":"Recommendations on Human Papillomavirus (HPV) Vaccines: Position Paper","year":"2022"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103890_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vaccine.2021.11.041","article-title":"Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: the Costa Rica ESCUDDO trial","volume":"40","author":"Porras","year":"2022","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103890_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S1473-3099(23)00313-4","article-title":"Biosimilar second-generation human papillomavirus vaccines","volume":"23","author":"Arroyo Muhr","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"10224","key":"10.1016\/j.eclinm.2026.103890_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103890_bib11","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1038\/s41467-024-47909-x","article-title":"Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer","volume":"15","author":"Arroyo Muhr","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103890_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14760584.2019.1568876","article-title":"Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies","volume":"18","author":"Lehtinen","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103890_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CVI.00591-14","article-title":"Efficacy of human papillomavirus 16 and 18 (HPV-16\/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial","volume":"22","author":"Apter","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103890_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrclinonc.2015.146","article-title":"HPV-FASTER: broadening the scope for prevention of HPV-related cancer","volume":"13","author":"Bosch","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"7\u20138","key":"10.1016\/j.eclinm.2026.103890_bib16","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1080\/21645515.2019.1619401","article-title":"Feasibility of a combined strategy of HPV vaccination and screening in Mexico: the FASTER-Tlalpan study experience","volume":"15","author":"Leon-Maldonado","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eclinm.2026.103890_bib17","series-title":"Comprehensive Cervical Cancer Control: a Guide to Essential Practice","year":"2014"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103890_bib18","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1016\/S2468-2667(24)00218-4","article-title":"Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden","volume":"9","author":"Wang","year":"2024","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103890_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jnci\/djaf297","article-title":"RE: Interval cervical cancers after self-sampling for human papillomavirus in the general population","volume":"18","author":"Gray","year":"2026","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eclinm.2026.103890_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2025.105869","article-title":"Assessing sample adequacy and clinical performance of self-collected and clinician-collected HPV specimens using internal control Ct values","volume":"181","author":"Martinelli","year":"2025","journal-title":"J Clin Virol"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103890_bib21","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1016\/S2468-2667(24)00240-8","article-title":"Implementation efforts to support transition to HPV-based cervical cancer screening","volume":"9","author":"Almonte","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.eclinm.2026.103890_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103290","article-title":"Global HPV vaccination programs and coverage rates: a systematic review","volume":"84","author":"Han","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103890_bib23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/13696998.2022.2082777","article-title":"Pricing of HPV tests in Italian tender-based settings","volume":"25","author":"Inturrisi","year":"2022","journal-title":"J Med Econ"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103890_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70022","article-title":"Continuous global improvement of human papillomavirus (HPV) genotyping services: the 2022 and 2023 HPV LabNet international proficiency studies","volume":"96","author":"Arroyo Muhr","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.eclinm.2026.103890_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105581","article-title":"First international proficiency study on human papillomavirus testing in cervical cancer screening","volume":"167","author":"Yilmaz","year":"2023","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103890_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70310","article-title":"Reflections regarding validation of new HPV tests with reduced HPV genotypes: report from an IARC expert consultation","volume":"97","author":"Ramirez","year":"2025","journal-title":"J Med Virol"},{"key":"10.1016\/j.eclinm.2026.103890_bib28","series-title":"Target Product Profiles for Human Papillomavirus Screening Tests to Detect Cervical Pre-Cancer and Cancer","year":"2024"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103890_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ijc.33519","article-title":"Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer","volume":"149","author":"Hortlund","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eclinm.2026.103890_bib30","series-title":"European Guidelines on cervical Cancer Screening and Diagnosis (February 2025)","year":"2025"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103890_bib32","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1093\/infdis\/jiaf032","article-title":"Population-based age-period-cohort analysis of declining human papillomavirus prevalence","volume":"231","author":"Gray","year":"2025","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103890_bib33","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/ijc.32848","article-title":"Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: population-based nested case-control study","volume":"146","author":"Kann","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eclinm.2026.103890_bib34","article-title":"The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage study","volume":"54","author":"Middeldorp","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103890_bib35","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.70229","article-title":"Controlled trial of cervical cancer screening frequency among human-papillomavirus-vaccinated women","volume":"158","author":"Ortega Llobet","year":"2026","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eclinm.2026.103890_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80905","article-title":"Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic","volume":"12","author":"Elfstrom","year":"2023","journal-title":"Elife"},{"issue":"10316","key":"10.1016\/j.eclinm.2026.103890_bib37","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.eclinm.2026.103890_bib38","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103890_bib39","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ijc.35081","article-title":"Cervical cancer incidence in Denmark: disentangling determinants of time trend","volume":"155","author":"Lynge","year":"2024","journal-title":"Int J Cancer"},{"issue":"41","key":"10.1016\/j.eclinm.2026.103890_bib40","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103890_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2497608","article-title":"Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: a systematic literature review","volume":"21","author":"Harper","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103890_bib42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41591-022-01738-x","article-title":"Priorities for cancer research in low- and middle-income countries: a global perspective","volume":"28","author":"Pramesh","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.eclinm.2026.103890_bib43","series-title":"Planning and Developing Population-Based Cancer Registration in Low- or Middle-Income Settings","author":"Bray","year":"2014"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:50:42Z","timestamp":1793944242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S2589537026001380"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103890","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and possible solutions towards reaching global cervical cancer elimination","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103869","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103895","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103890"}}